Brief: Pacira Biosciences Files Exparel Patent Infringement Lawsuits Against The Whiteoak Group And Qilu Pharmaceutical
26/11/2025 21:04
Nov 26 (Reuters) - Pacira Biosciences Inc PCRX.O: PACIRA BIOSCIENCES FILES EXPAREL® PATENT INFRINGEMENT LAWSUITS AGAINST THE WHITEOAK GROUP AND QILU PHARMACEUTICAL PACIRA BIOSCIENCES: SEEKS INJUNCTION TO PREVENT MANUFACTURE, USE, SALE OF GENERIC PRODUCTS DESCRIBED IN EACH CO'S ANDA FILED WITH U.S. FDA PACIRA BIOSCIENCES: LAWSUITS TRIGGERED 30-MONTH STAY OF FINAL FDA APPROVAL OF ANDAS UNDER HATCH WAXMAN ACT Source text: ID:nGNX8dzT1v Further company coverage: PCRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees